查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555516

外用抗生素市場、副產品、藥物、應用、配銷通路和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Topical Antibiotics Market, By Product, By Drug, By Application, By Distribution Channel, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年，外用抗生素市場規模為 53.152 億美元，2024 年至 2032 年複合年成長率為 5.00%。

外用抗生素市場-市場動態

皮膚感染盛行率的增加支持外用抗生素市場的成長

據世界衛生組織稱，全球約有 9 億人患有蜂窩性組織炎、細菌性皮膚炎、痤瘡和膿皰瘡等皮膚病。低度開發國家的主要原因之一是傳染病。由細菌引起的皮膚感染在患有某些合併症的人中也更常見。這些疾病包括糖尿病、血管功能不全和免疫系統受損，特別是在接受化療且出現嗜中性白血球減少症的個體中。在全球範圍內，由於生活方式的改變、衛生習慣不良（特別是在發展中國家）以及速食攝入量的增加等多種因素，細菌性皮膚感染的盛行率一直在增加。因此，皮膚感染盛行率的上升推動了對局部抗生素治療細菌性皮膚病的需求。

外用抗生素市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 5.00% 左右的複合年成長率成長

根據產品細分，預計軟膏類別將在 2023 年佔據最大市場佔有率

從藥品細分來看，2023年四環素類為主導細分市場

從應用細分來看，皮膚感染類是2023年的主導細分領域

按地區分類，北美是 2023 年的主要收入來源

外用抗生素市場-細分分析：

全球外用抗生素市場根據產品、藥物、應用、配銷通路和地區進行細分。

市面上依藥物分為以下幾類：氨基糖苷類、四環素、紅黴素、克林黴素等。四環素類別在市場上佔據主導地位。四環素透過防止細菌生長和繁殖而發揮作用。許多皮膚感染，包括紅斑性痤瘡、痤瘡和細菌性表淺皮膚感染，已被證明對四環素治療有良好的反應。它有效應對這些情況的能力提高了其市場需求。四環素對多種細菌有效，包括革蘭氏陽性菌和革蘭氏陰性菌。其適應性使其成為治療多種細菌性疾病的首選，從而推動了其市場擴張。

根據配銷通路，市場分為三類：醫院藥房、零售藥房和其他。零售藥局類別在市場中佔據主導地位，並可能在預測期內保持其主導地位。消費者可以輕鬆前往零售藥局和藥局，那裡提供各種處方藥和非處方藥，包括外用抗生素。無論人們是想要治療輕微感染，還是醫療保健專業人員開出局部抗生素處方，這些商店都是購買抗生素的便利場所。零售藥局也經常提供藥物諮詢等額外服務，從而提高客戶滿意度和忠誠度。因此，零售藥局和藥局通路的廣泛覆蓋範圍和易用性增強了其市場主導地位。

外用抗生素市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

在預測期內，北美預計將佔據全球外用抗生素市場的最大佔有率。皮膚感染很常見，包括膿皰瘡和細菌感染。皮膚病具有傳染性，原因有很多，包括清潔不足、擁擠環境中的親密接觸以及特定的危險因子。由於皮膚感染盛行率的增加，對有效抗菌霜的需求不斷成長。在美國，對於 1 歲至 19 歲的兒童來說，燒傷和火災是傷害相關死亡的第七大常見原因。在北美，藥品市場的成長在一定程度上要歸功於強大的醫療基礎設施。

此外，亞太地區的外用抗生素市場預計在預測期內將以全球最快的速度擴張。預計該地區對皮膚科抗生素的需求將受到中國和印度等人口稠密國家不斷成長的人口密度和不衛生條件的推動。由於有利的監管環境、大量的研究支出以及與全球製藥公司的合作，亞太地區的製藥業正在快速成長。

外用抗生素市場-競爭格局：

競爭激烈的外用抗生素市場有多家參與者。輝瑞公司（Pfizer Inc.）、諾華公司（Novartis AG）、拜耳公司（Bayer AG）、禮來公司（Lilly）、默克公司（Merck & Co., Inc.）和太陽製藥工業有限公司（Sun Pharmaceutical Industries Ltd.）等主要參與者正在透過滿足各種治療需求的各種產品組合積極爭取市場佔有率。競賽重點在於產品功效、安全性、成本和分銷等多個重要方面，凸顯創新對於阻止抗生素抗藥性和維持市場競爭力的重要性。

最新進展：

2024 年1 月：美國市場即將迎來CABTREO™（克林黴素、阿達帕林、過氧化苯甲醯）外用凝膠1.2%/0.15%/3.1%，這是Bausch Health Companies Inc. 及其皮膚科部門Ortho Dermatologics 的新產品。該凝膠旨在幫助患有尋常性痤瘡的成人和 12 歲或以上的青少年。

2023 年12 月：FDA 已批准Filsuvez，一種含有樺木三萜的外用凝膠，用於治療6 個月或以上的交界性大皰性表皮鬆解症(JEB) 和營養不良性大皰性表皮松解症(DEB) 患者的部分厚度傷口。

目錄

第1章：外用抗生素市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品分類的外用抗生素市場片段
    • 按藥物分類的外用抗生素市場片段
    • 依應用分類的外用抗生素市場片段
    • 按配銷通路分類的外用抗生素市場片段
    • 按國家/地區分類的外用抗生素市場摘要
    • 按地區分類的外用抗生素市場片段
  • 競爭洞察

第 3 章：外用抗生素主要市場趨勢

  • 外用抗生素市場促進因素
    • 市場促進因素的影響分析
  • 外用抗生素市場限制
    • 市場限制影響分析
  • 外用抗生素市場機會
  • 外用抗生素市場未來趨勢

第 4 章：外用抗生素產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：外用抗生素市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：外用抗生素市場格局

  • 2023 年外用抗生素市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：外用抗生素市場 - 副產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 乳霜
    • 藥膏
    • 凝膠
    • 粉末
    • 其他

第 8 章：外用抗生素市場 - 按藥物分類

  • 概述
    • 按藥物分類的細分市場佔有率分析
    • 氨基糖苷類
    • 四環素
    • 紅黴素
    • 克林黴素
    • 其他

第 9 章：外用抗生素市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 眼部感染
    • 皮膚感染
    • 狐狸臭
    • 其他

第 10 章： 外用抗生素市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 其他

第 11 章：外用抗生素市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美局部用抗生素主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品）
    • 北美市場規模和預測（按藥物）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲局部用抗生素主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按產品）
    • 歐洲市場規模與預測（按藥品）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區外用抗生素主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按產品）
    • 亞太地區藥物市場規模與預測
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲局部用抗生素主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品）
    • 拉丁美洲市場規模與預測（按藥品）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲局部用抗生素主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（按藥品）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 外用抗生素產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • Novartis AG
    • Bayer AG
    • Lilly
    • Merck & Co., Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • Lupin
    • GlaxoSmithKline Plc
    • Almirall, SA
    • Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
    • Medimetriks Pharmaceuticals, Inc.
    • Taro Pharmaceutical Industries Ltd.
    • Chiesi Global Rare Diseases
    • Mayne Pharma Group Limited
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3578

REPORT HIGHLIGHT

Topical Antibiotics Market size was valued at USD 5,315.2 Million in 2023, expanding at a CAGR of 5.00% from 2024 to 2032.

Topical antibiotics are medications that are administered topically to the skin or mucous membranes in order to treat bacterial infections. They come in a variety of forms, including lotions, creams, ointments, gels, and solutions. Common causes of bacterial infections include Staphylococcus aureus, Streptococcus viridians, and Streptococcus pyogenes. High concentrations of antibiotics at the infection site are necessary for effective treatment; retapamulin and mugirocin are common options. When the skin is unbroken, very little systemic absorption takes place. Even though many infections may be treated outside of hospitals, there are serious hazards involved in leaving situations untreated.

Topical Antibiotics Market- Market Dynamics

Increase in Skin Infection Prevalence Supporting Market Growth for Topical Antibiotics

According to the World Health Organization, about 900 million individuals worldwide suffer from skin conditions like cellulitis, bacterial dermatitis, acne, and impetigo impact. One of the main causes of death in underdeveloped nations is infectious diseases. Skin infections caused by germs are also more common in people with certain comorbid diseases. These ailments include diabetes, vascular insufficiency, and impaired immune systems, particularly in individuals receiving chemotherapy who experience neutropenia. Globally, the prevalence of bacterial skin infections has been increasing due to various factors such as alterations in lifestyle, inadequate hygiene habits, particularly in developing nations, and increased intake of fast food. Thus, the need for topical antibiotics for bacterial skin illnesses is being driven by the rising prevalence of skin infections.

Topical Antibiotics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.00% over the forecast period (2024-2032)

Based on product segmentation, the ointments category was predicted to show maximum market share in the year 2023

Based on drug segmentation, the tetracycline category was the leading segment in 2023

Based on application segmentation, the skin infection category was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Topical Antibiotics Market- Segmentation Analysis:

The Global Topical Antibiotics Market is segmented on the basis of Product, Drug, Application, Distribution Channel and Region.

The market is divided into the following categories based on drug: Aminoglycosides, Tetracycline, Erythromycin, Clindamycin, and Others. The tetracycline category dominates the market. Tetracycline works by preventing bacterial growth and multiplication. Numerous skin infections, including rosacea, acne, and bacterial superficial skin infections, have been shown to respond well to tetracycline treatment. Its ability to effectively combat these situations raises its market demand. Tetracycline is effective on a wide range of bacteria, including Gram-positive and Gram-negative species. Its adaptability makes it a top option for treating a variety of bacterial diseases, which fuels its market expansion.

The market is divided into three categories based on distribution channel: Hospital Pharmacies, Retail Pharmacies, and Others. The retail pharmacies category dominates the market and is likely to maintain its dominance during the forecast period. Consumers can easily access retail pharmacies and drug stores, which provide a variety of prescription and over-the-counter drugs, including topical antibiotics. Whether people are looking to treat minor infections or are prescribed topical antibiotics by healthcare professionals, these stores are convenient places to buy them. Retail pharmacies also frequently offer extra services like medication counseling, which increases customer satisfaction and loyalty. Consequently, retail pharmacies and drugstore channels' extensive reach and ease of use add to their market domination.

Topical Antibiotics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for Topical Antibiotics. Skin infections are common, including impetigo and bacterial infections. Skin disorders are contagious because of a number of circumstances, including inadequate cleanliness, close closeness in crowded settings, and particular risk factors. The need for effective antimicrobial creams is growing due to the increased prevalence of skin infections. In children between the ages of one and nineteen, burns and fires are the seventh most common cause of injury-related deaths in the US. In North America, the pharmaceutical market is growing thanks in part to a strong healthcare infrastructure.

In addition, the Topical Antibiotics market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The need for dermatological antibiotics in the region is expected to be driven by the growing population density and unhygienic conditions found in populated countries like China and India. The Asia Pacific region's pharmaceutical industry is growing quickly thanks to favorable regulatory environments, significant research expenditures, and cooperative efforts with global pharmaceutical companies.

Topical Antibiotics Market- Competitive Landscape:

There are several players in the fiercely competitive topical antibiotics market. Major players such as Pfizer Inc., Novartis AG, Bayer AG, Lilly, Merck & Co., Inc., and Sun Pharmaceutical Industries Ltd., among others, are aggressively competing for market share with a variety of product portfolios catered to various therapeutic specializations. The competition focuses on a number of important aspects, such as product efficacy, safety, cost, and distribution, highlighting how crucial innovation is to halting antibiotic resistance and maintaining market competitiveness.

Recent Developments:

January 2024: The US market is set to welcome CABTREOTM (clindamycin, adapalene, benzoyl peroxide) Topical Gel, 1.2%/0.15%/3.1%, as a new product from Bausch Health Companies Inc. and Ortho Dermatologics, their dermatological division. This gel is designed to aid adults and teenagers with acne vulgaris who are 12 years of age or older.

December 2023: The FDA has approved Filsuvez, a topical gel containing birch triterpenes, for the treatment of partial thickness wounds in patients with Junctional Epidermolysis Bullosa (JEB) and Dystrophic Epidermolysis Bullosa (DEB) who are six months of age or older, according to a statement released by Chiesi Global Rare Diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TOPICAL ANTIBIOTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Lilly
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • GlaxoSmithKline Plc
  • Almirall, S.A.
  • Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
  • Medimetriks Pharmaceuticals, Inc.
  • Taro Pharmaceutical Industries Ltd.
  • Chiesi Global Rare Diseases
  • Mayne Pharma Group Limited
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Creams
  • Ointments
  • Gels
  • Powder
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY DRUG- MARKET ANALYSIS, 2019 - 2032

  • Aminoglycosides
  • Tetracycline
  • Erythromycin
  • Clindamycin
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Eye Infection
  • Skin Infection
  • Bromhidrosis
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

GLOBAL TOPICAL ANTIBIOTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Topical Antibiotics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Topical Antibiotics Market Snippet by Product
    • 2.1.2. Topical Antibiotics Market Snippet by Drug
    • 2.1.3. Topical Antibiotics Market Snippet by Application
    • 2.1.4. Topical Antibiotics Market Snippet by Distribution Channel
    • 2.1.5. Topical Antibiotics Market Snippet by Country
    • 2.1.6. Topical Antibiotics Market Snippet by Region
  • 2.2. Competitive Insights

3. Topical Antibiotics Key Market Trends

  • 3.1. Topical Antibiotics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Topical Antibiotics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Topical Antibiotics Market Opportunities
  • 3.4. Topical Antibiotics Market Future Trends

4. Topical Antibiotics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Topical Antibiotics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Topical Antibiotics Market Landscape

  • 6.1. Topical Antibiotics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Topical Antibiotics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Creams
    • 7.1.3. Ointments
    • 7.1.4. Gels
    • 7.1.5. Powder
    • 7.1.6. Others

8. Topical Antibiotics Market - By Drug

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug, 2023 & 2032 (%)
    • 8.1.2. Aminoglycosides
    • 8.1.3. Tetracycline
    • 8.1.4. Erythromycin
    • 8.1.5. Clindamycin
    • 8.1.6. Others

9. Topical Antibiotics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Eye Infection
    • 9.1.3. Skin Infection
    • 9.1.4. Bromhidrosis
    • 9.1.5. Others

10. Topical Antibiotics Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 10.1.2. Hospital Pharmacies
    • 10.1.3. Retail Pharmacies
    • 10.1.4. Others

11. Topical Antibiotics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Topical Antibiotics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Topical Antibiotics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Topical Antibiotics Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Topical Antibiotics Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Topical Antibiotics Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Topical Antibiotics Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Novartis AG
    • 12.2.3. Bayer AG
    • 12.2.4. Lilly
    • 12.2.5. Merck & Co., Inc.
    • 12.2.6. Sun Pharmaceutical Industries Ltd.
    • 12.2.7. Aurobindo Pharma
    • 12.2.8. Lupin
    • 12.2.9. GlaxoSmithKline Plc
    • 12.2.10. Almirall, S.A.
    • 12.2.11. Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
    • 12.2.12. Medimetriks Pharmaceuticals, Inc.
    • 12.2.13. Taro Pharmaceutical Industries Ltd.
    • 12.2.14. Chiesi Global Rare Diseases
    • 12.2.15. Mayne Pharma Group Limited
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us